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This case report highlights the immunological
considerations in patients who are diagnosed
with disseminated infection due to BCG or
environmental mycobacteria.
Case history
A 17-year-old boy presented with a four-week
history of neck pain, difficulty chewing and devi-
ation of his tongue to the right. On examination
there was tenderness of the mid-cervical spine and
a right XII nerve palsy. A 6 cm lesion was noted
over the left deltoid (Figure 1). There was no lym-
phadenopathy or splenomegaly. Blood tests were
normal apart fromESR 44 mm/h andCRP 83mg/L.
Cervical spine X-rays showed increased space
between the odontoid peg and the arch of C1. CT
of the neck revealed destruction of the basisphe-
noid, clivus and right occipital condyle, with
craniocervical instability. The cervical spine was
immobilized with a hard collar pending halo
fixation. Gadolinium-enhanced MRI showed a T1
signal abnormality around the hypoglossal nerve
and involving the anterior foramen magnum and
the right side of the C1 vertebra. 99mTc bone scinti-
graphy revealed increased uptake in the sacrum,
right iliac crest, right eighth rib and left
acetabulum.
Following BCG vaccination four years pre-
viously the patient developed a chronic 6 cm dis-
charging lesion at the inoculation site. This was
biopsied one year prior to his presentation with
neck pain. Histology demonstrated necrotizing
granulomas and BCG was cultured. He defaulted
follow-up and failed to complete antimycobacter-
ial therapy.
The right iliac crest was biopsied and histology
revealed non-caseating granulomatous inflam-
mation. Although staining for AAFB was nega-
tive, rifampicin, isoniazid and ethambutol were
commenced for presumed disseminated BCG.
Culture confirmed BCG at 7 weeks, sensitive to
rifampicin, isoniazid and ethambutol, resistant to
pyrazinamide.
The patient’s neck pain and XII nerve palsy
resolved and his cutaneous lesion began to heal. A
bone scan at 5 months showed reduced uptake in
the right iliac crest and no additional abnormality.
CT of the cervical spine at 9 months indicated
fusion of the right occiput to C1. Triple therapy
was continued for 1 year followed by rifampicin+
isoniazid for a further year. Nuclear magnetic spec-
troscopy 1 year after discontinuing therapy showed
improvement and the patient remains well.
He had no history of infection with bacteria,
viruses or fungi, suggesting an isolated predispo-
sition to mycobacteria. He was HIV-negative with
normal immunoglobulin levels, IgG subclasses,
complement levels and normal levels of specific
antibodies to all the childhood vaccinations. Lym-
phocyte subsets showed generalized depression,
attributed to disseminated infection, but normal
percentages. Major histocompatibility complex
class I & II expression was normal. He had
normal adenosine deaminase and purine nucleo-
side phosphorylase levels, normal lymphocyte
proliferative responses, normal neutrophil oxi-
dative burst function and normal Toll-like receptor
(TLR) 4 and TLR 7/9 screening by CD62L shed-
ding assay.
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The patient’s brother had also experienced an
extensive cutaneous reaction to BCG and both
were screened for defects in the IL-12/IFN-γ
pathway, described below. Known defects were
excluded. Anti-IFNγ autoantibodies were weakly
positive but unlikely to be significant.
Discussion
Disseminated infection caused by BCG or environ-
mental mycobacteria (EM) suggests a primary or
acquired immunodeficiency, such as severe com-
bined immunodeficiency, chronic granulomatous
disease or HIV. A leaky cellular immunodefi-
ciency was considered in the above case but
immunological investigations were normal as
listed. Given the isolated predisposition to BCG
in two siblings, with no other demonstrable
immune defect, an inherited deficiency in the
IL-12/IFN-γ axis was considered most likely.
Such disorders have been described relatively
recently and are termed ‘Mendelian susceptibility
to mycobacterial disease’ (MSMD). In addition to
BCG and EM, affected individuals are prone to
extra-intestinal disease caused by non-typhoidal
Salmonella.1 In this patient’s case, screening
excluded currently known deficiencies of the
IL-12/IFN-γ axis, suggesting a novel defect.
The IL-12/IFN-γ pathway
Dendritic cells and macrophages act as antigen-
presenting cells (APCs) which recognize invad-
ing mycobacteria through pattern recognition
receptors. Signal transduction leads to activation
of the APC and production of IL-12 and IL-23.2
These cytokines bind to their receptors on
T-helper and natural killer cells, inducing pro-
duction of IFN-γ. The IL-12 receptor (IL-12R) is a
complex of IL-12Rβ1 and IL-12Rβ2.2 IL-12 consists
of p40 and p35 subunits which bind to IL-12Rβ1
and IL-12Rβ2, respectively.
Secreted IFN-γ binds to its receptor (IFN-γR) on
dendritic cells and macrophages, activating micro-
bicidal mechanisms. The IFN-γR is composed of
two chains, IFN-γR1 and IFN-γR2.2
Mendelian susceptibility to
mycobacterial disease
Mutations have been identified in six genes:
IFNGR1 and IFNGR2 (encoding IFN-γR1 and
IFN-γR2), STAT1 (encoding signal transducer and
activator of transcription-1: Stat-1), IL12P40 (encod-
ing IL-12p40), IL12RB1 (encoding IL-12Rβ1) and
NEMO (encoding nuclear factor-κB-essential
modulator:NEMO).1,3Mutationsmaybe associated
with partial or complete deficiency of the gene
product.
IFN-γR1 and IFN-γR2 deficiency
Complete recessive deficiency of IFN-γR1 or
IFN-γR2 presents with early severe, often fatal,
infection with BCG and EM.1 There is no cellular
response to IFN-γ in vitro.1 Haematopoietic stem
cell transplantation has been curative in a few cases.4
Partial recessive IFN-γR1 deficiency diminishes
the cellular response to IFN-γ.5 Patients present
with less severe mycobacterial infection which
usually responds to antimicrobials +/– IFN-γ.3
Dominant IFNGR1 mutations produce trun-
cated receptors with a weak cellular response to
IFN-γ.1,3 Children develop moderately severe
infection with BCG and EM.6 M. avium osteomyel-
itis has been repeatedly described.6 Outcome is
generally good with antimicrobials +/– IFN-γ.3
Partial recessive IFN-γR2 deficiency has been
reported in a child who presented with mild
BCG and M. abscessus infection.7 Partial dominant
IFN-γR2 deficiency has been described in one
family, causing M. abscessus osteomyelitis in one
of two homozygous siblings, and disseminated
CMV and M. avium infection in the other.8
Figure 1
BCG site, four years after inoculation
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Stat-1 deficiency
Stat-1 is a downstream signalling molecule for
IFN-γ.1 Dominant STAT1 mutations cause a partial
deficiency with a mild clinical phenotype.1,9
IL-12p40 and IL-12Rβ1 deficiency
Recessive mutations in IL12B result in complete
deficiency with undetectable IL-12p40.1 Recessive
mutations in IL12RB1 result in complete IL-12Rβ1
deficiency, with no cellular response to IL-12.3 In
both cases infection with BCG or Salmonella is
common and usually responds to antimicrobials
and IFN-γ.1,3
X-linked recessive MSMD: mutations
in NEMO
NEMO is a regulatory subunit of the nuclear
factor-κB (NFκB) inhibitor kinase complex which
controls activation of the transcription factor
NFκB, implicated in various immunological path-
ways.2 Mutations in NEMO have been associated
with predisposition to mycobacterial infection.10
Conclusion
We speculate that the case presented represents a
novel variant of MSMD. Patients with dissemi-
nated or recurrent infection due to BCG or EM,
with a severe persistent cutaneous reaction to
BCG, or with extra-intestinal infection caused by
non-typhoidal Salmonella, should be investigated
for a defect in cell-mediated immunity. Consider
screening for MSMD, after exclusion of HIV, par-
ticularly if family members are symptomatic.
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